Миопатии

7. Bieber, F. R., Hoffman, E. P., and Amos, J. A. Dystrophin analysis in Duchenne muscular dystrophy: Use in fetal diagnosis and in genetic counseling. Am. J. Hum. Genet. 45:362, 1989.

8. Fenichel, G. M., et al. Long term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41:1874, 1991.

9. Hardiman, O., et al. Neuropathic findings in oculopharyngeal muscular dystrophy: A report of seven cases and a review of the literature. Arch. Neurol. 50(5):481, 1993.

10. Harris, S. E., and Cherry, D. B. Childhood progressive muscular dystrophy and the role of physical therapy. Phys. Ther. 54:4, 1974.

11. Hook, R., Anderson, E. F., and Noto, P. Anesthetic management of a parturient with myotonia atrophica. Anesthesiology 43:689, 1975.

12. Iannaccone, S. T. Current status of Duchenne muscular dystrophy. Pediatr. Clin. North Am. 39(4):879, 1992.

13. Love, D. R., et al. Dystrophin and dystrophin-related proteins: A review of protein and RNA studies. Neuromuscul. Disord. 3(1):5, 1993.

14. Miller, G., and Wessel, H. B. Diagnosis of dystrophinopathies: Review for the clinician. Pediatr. Neurol. 9(1):3, 1993.

15. Sarnat, H. B., O'Connor, T., and Byrne, P. A. Clinical effects of myotonic dystrophy on pregnancy and the neonate. Arch. Neurol. 33:459, 1976.

16. Wessel, H. B. Dystrophin: A clinical perspective. Pediatr. Neurol. 6(1):3, 1990.

17. Zellweger, M. D., and Ionasecu, V. Myotonic dystrophy and its differential diagnosis. Acta Neurol. Scand. (Suppl. 55) 49:1, 1973.